Ian BryanApr 131 minJuno Awarded Additional $389 Million ‘Enhanced Damages’ for Wilful Infringement by KiteAs previously reported, in December last year a Californian court held that Gilead Sciences’ Kite Pharma’s sales of its blood cancer immu...
Ian BryanDec 29, 20192 minCRISPR/Cas9 Patent DisputeWhile the past year has been eventful in the CRISPR/Cas9 patent dispute, the question still remains as to whether the Broad Institute or ...
Ian BryanDec 17, 20191 minJuno Awarded $752 Million as Friday 13th CAR-T Patent Ruling Goes against Kite Pharma On Friday 13th December 2019 a Californian court ruled against Kite Pharma, holding that its blood cancer therapy Yescarta infringed Juno...
Ian BryanNov 23, 20182 minCRISPR/Cas9 Patent Wars In September 2018 the US Federal Court of Appeal upheld a lower court’s decision in favour of the Broad Institute, finding that Broad’s c...
